Journal of Affective Disorders
Volume 74, Issue 2 , Pages 149-158 , April 2003

Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide

  • C. van Heeringen

      Affiliations

    • Unit for Suicide Research, Department of Psychiatry, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32-9-240-4395; fax: +32-9-240-4989
    • ,
  • K. Audenaert

      Affiliations

    • Unit for Suicide Research, Department of Psychiatry, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium
    • Department of Nuclear Medicine, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium
    • ,
  • K. Van Laere

      Affiliations

    • Department of Nuclear Medicine, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium
    • ,
  • F. Dumont

      Affiliations

    • Department of Radiopharmacy, University of Gent, Gent, Belgium
    • ,
  • G. Slegers

      Affiliations

    • Department of Radiopharmacy, University of Gent, Gent, Belgium
    • ,
  • J. Mertens

      Affiliations

    • VUB Cyclotron, Brussels, Belgium
    • ,
  • R.A. Dierckx

      Affiliations

    • Department of Nuclear Medicine, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium

Received 30 November 2000 ,Revised 4 December 2001 ,Accepted 5 December 2001.

References 

  1. Abi-Dargham A, Zea Ponce Y, Terriere D, Al Tikriti M, Baldwin R, Hoffer P, et al. Preclinical evaluation of [I-123] R93274 as a SPECT radiotracer for imaging 5-HT2a receptors. Eur. J. Pharmacol. 1997;321:285–293
  2. Apter A, Ofek H. Personality constellations in suicidal behaviour. In:  Van Heeringen K editors. Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Prevention. Chichester, UK: Wiley; 2001;
  3. Apter A, Plutchik R, Van Praag H. Anxiety, impulsivity and depressed mood in relation to violent and suicidal behaviour. Acta Psychiatr. Scand. 1993;87:1–5
  4. Åsberg M, Träskman L, Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor?. Arch. Gen. Psychiatry. 1976;33:1193–1197
  5. Attar-Lévy D, Martinot J, Blin J, Dao-Castellana M, Crouzel C, Mazoyer B, et al. The cortical serotonin-2 receptors studied with positron-emission tomography and 18F-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol. Psychiatry. 1999;45:180–186
  6. Arora R, Meltzer H. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry. 1989;146:730–736
  7. Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, Van Heeringen K, et al. Decreased prefrontal serotonin 5-HT2a receptor binding potential in deliberate self harm patients. Eur. J. Nucl. Med. 2000;28:175–182
  8. Baeken C, D’Haenen H, Flamen P, Mertens J, Terriere D, Chavatte K, et al. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2a receptors: influence of age and gender in healthy subjects. Eur. J. Nucl. Med. 1998;25:1617–1622
  9. Beck A, Weissmann A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J. Consult. Clin. Psychol. 1974;42:861–865
  10. Biegon A, Weizman A, Karp L, Ram A, Tiano S, Wolff M. Serotonin 5-HT2 receptor binding on blood platelets: a peripheral marker for depression?. Life Sci. 1987;41:2485–2492
  11. Busatto G, Pilowsky L, Costa D, Mertens J, Terriere D, Ell P, et al. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy subjects. Eur. J. Nucl. Med. 1997;24:119–124
  12. Cloninger C, Svrakic D, Przybeck T. A psychobiological model of temperament and character. Arch. Gen. Psychiatry. 1993;30:975–990
  13. Cloninger C, Przybeck T, Svrakic D, Wetzel R. The Temperament and Character Inventory (TCI): A Guide to its Development and Use. St Louis, MO: Center for Psychobiology of Personality; 1994;
  14. Cloninger C. The genetics and psychobiology of the seven-factor model of personality. In:  Silk K editors. Biology of Personality Disorders. Washington, DC: American Psychiatric Press; 1998;p. 63–93
  15. Coccaro E, Siever L, Klar H, Maurer G, Cochrane K, Cooper T, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch. Gen. Psychiatry. 1989;46:587–599
  16. Deakin J. 5-HT, antidepressant drugs and the psychosocial origins of depression. J. Psychopharmacol. 1996;10:31–38
  17. D’Haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L. SPECT imaging of serotonin 2 receptors in depression. Psychiatry Res. Neuroimaging. 1992;45:227–237
  18. Duijsens I, Goekoop J, Spinhoven P, Eurelings-Bontekoe E. De temperament en karakter vragenlijst (TCI). Ned. Tijdschr. Psychol. 1997;52:199–202
  19. Folstein M, Folstein S, McHugh P. ‘Mini-Mental State’: a practical method for grading the cognitive state of the patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  20. Fuster JM. The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe. 3rd Edition. Philadelphia, PA: Lippincott-Raven; 1997;
  21. Gjerris A. Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression?. Acta Psychiatr. Scand. 1988;345:21–24
  22. Green A, Johnson P, Mountford J, Nimgaonkar V. Some anticonvulsant drugs alter monoamine medicated behaviour in mice in ways similar to electroconvulsive shock: implications for antidepressant therapy. Br. J. Pharmacol. 1985;84:337–346
  23. Gross-Iseroff R, Salama D, Israeli M, Biegon A. Autoradiographic analysis of age-dependent changes in serotonin 5HT2 receptor of the human brain postmortem. Brain Res. 1990;507:223–227
  24. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  25. Harris EC, Barraclough B. Excess mortality of mental disorder. Br. J. Psychiatry. 1998;173:11–53
  26. Hawton K, Arensman E, Townsend E, Bremner S, Feldman E, Goldney R, et al. Deliberate self harm: systematic review of the efficacy of psychosocial and pharmacological interventions in preventing repetition. Br. Med. J. 1998;317:441–447
  27. Hawton K, Catalan J. Attempted Suicide: A Practical Guide to its Nature and Management. Oxford: Oxford Medical Publications; 1987;
  28. Hawton K, Van Heeringen K. The International Handbook of Suicide and Attempted Suicide. Chichester, UK: Wiley; 2000;
  29. Leysen J, Van Gompel P, de Chaffoy de Courcelles D, Niemegeers C. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade. J. Recept. Res. 1987;7:223–229
  30. Lowther S, De Parmentier F, Crompton M, Katona C, Horton R. Brain 5HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 1994;642:281–289
  31. Madden I. Neurobiology of Learning, Emotion and Affect. New York: Raven Press; 1991;
  32. Mann E, Enna S. Neurochemical and behavioral correlates of antidepressant drug action. Life Sci. 1982;30:1653–1661
  33. Mann J, Stanley M, McBride P, McEwen B. Increased serotonin 2 and beta-adrenergic receptor binding in the frontal cortex of suicide victims. Arch. Gen. Psychiatry. 1986;43:954–959
  34. Mann J, Malone K, Sweeney J, Brown R, Linnoila M, Stanley B, et al. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed patients. Neuropsychopharmacology. 1996;15:576–586
  35. Massou J, Trichard C, Attar-Levy D, Feline A, Corruble E, Beaufils B, et al. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology. 1997;133:99–101
  36. Meerschaert, T., Audenaert, K., Van Heeringen, C., submitted. Temperament en karakter in Vlaanderen: een onderzoek naar de distributie van persoonlijkheidsdimensies (Temperament and character in Flanders: a study of the distribution of personality dimensions).
  37. Mertens J, Terriere D, Sipido V, Gommeren W, Janssen P, Leysen J. Radiosynthesis of a new radioiodinated ligand for serotonin-5HT2-receptors, a promising tracer for gamma-emission tomography. J. Lab. Compd. Radiopharm. 1994;34:795–806
  38. Nordström P, Åsberg M. Suicide risk and serotonin. Int. Clin. Psychopharmacol. 1992;6(Suppl. 6):12–21
  39. Palmer A, Lowe S, Francis P, Bowen D. Are post-mortem biochemical studies of human brain worthwhile?. Biochem. Soc. Trans. 1988;16:472–475
  40. Pazos A, Probst A, Palacios J. Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 1987;21:123–139
  41. Peroutka S, Snyder S. Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science. 1980;210:88–90
  42. Pollock L, Williams J. Problem solving and suicidal behavior. Suicide Life-Threat. Behav. 1999;28:375–388
  43. Schoups A, Dillen L, Claeys M. Characterization of serotonin receptors and lack of effect of antidepressant therapy on monoamine functions in various regions of the rabbit brain. Eur. J. Clin. Pharmacol. 1986;126:259–271
  44. Stockmeier C. Neurobiology of serotonin in depression and suicide. In:  Mann J,  Stoff D editor. The Psychobiology of Suicide. New York: New York Academy of Sciences; 1997;p. 220–232
  45. Travis M, Busatto G, Pilowsky L, Mulligan R, Acton P, Gacinovic S, et al. 5-HT2a receptor blockade in patients with schizophrenia treated with risperidone and clozapine. A SPET study using the novel 5-HT2a ligand 123I-5-I-R-91150. Br. J. Psychiatry. 1998;173:236–241
  46. Van Heeringen K. Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Prevention. Chichester, UK: Wiley; 2001;
  47. Van Heeringen K, Audenaert K, Van de Wiele L, Verstraete A. Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J. Affect. Disord. 2000;60:181–189
  48. Van Praag H. Serotonin-related, anxiety/aggression driven, stressor-precipitated depression. A psychobiological hypothesis. Eur. Psychiatry. 1996;11:57–67
  49. Van Praag H. About the biological interface between psychotraumatic experiences and affective regulation. In:  Van Heeringen K editors. Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Prevention. Chichester, UK: Wiley; 2001;
  50. Wagner H, Reches A, Yablonskaya E, Fahn S. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex. In:  Fahn S, et al. editor. Myoclonus. New York: Raven Press; 1986;p. 645–651
  51. Wamsley J, Byerley W, McCabe R. Receptor alterations associated with serotonergic agents—an autoradiographic analysis. J. Clin. Psychiatry. 1987;48(Suppl. 3):19–25
  52. Williams JMG, Pollock L. The psychology of suicidal behaviour. In:  Hawton K,  Van Heeringen K editor. The International Handbook of Suicide and Attempted Suicide. Chichester, UK: Wiley; 2000;p. 79–95

PII: S0165-0327(01)00482-7

doi: 10.1016/S0165-0327(01)00482-7

Journal of Affective Disorders
Volume 74, Issue 2 , Pages 149-158 , April 2003

Article Tools